Estramustine (Emcyt Estracit) is a antimicrotubule chemotherapy agent used to treat prostate cancer. It is a derivative of oestrogen (specifically estradiol) with a nitrogen mustard-carbamate ester moiety. It has been withdrawn from a number of markets (Australia Brazil Ireland and Norway).
This page contains content from the copyrighted Wikipedia article "Estramustine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
